The NOMOLINE brand, founded in 2014 (United States), from 61 sister brands and 4472 competing brands. NOMOLINE is owned by MASIMO CORPORATION, listed on the stock exchange of New York NOMOLINE belongs to the Medical Devices & Instruments business sector.
Investment simulator :
Portfolio valuation
MASIMO CORPORATION
(NOMOLINE)
over 5 years*
USD 138.93